Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Anticancer Research|August 5, 2010
Phase III study comparing sequential versus alternate administration of cisplatin-etoposide and topotecan as first-line treatment in small cell lung cancerSophia Baka, Sophia Agelaki, Athanasios Kotsakis, et al.
Cancer|May 11, 2013
Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 studyAthanasios Karampeazis, Alexandra Voutsina, John Souglakos, et al.
Molecular Oncology|November 22, 2024
Integrative analysis of circulating tumor cells (CTCs) and exosomes from small-cell lung cancer (SCLC) patients: a comprehensive approachDimitrios Papakonstantinou, Argyro Roumeliotou, Evangelia Pantazaka, et al.
Cancers|July 13, 2024
Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer PatientsAnastasia Xagara, Maria Goulielmaki, Sotirios P Fortis, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2011
Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)Ioannis Boukovinas, Nikolaos Androulakis, Nikolaos Kentepozidis, et al.
Cells|May 10, 2024
Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer PatientsArgyro Roumeliotou, Areti Strati, Foteini Chamchougia, et al.
Cancers|June 2, 2021
Generation of Non-Small Cell Lung Cancer Patient-Derived Xenografts to Study Intratumor HeterogeneityZoi Kanaki, Alexandra Voutsina, Athina Markou, et al.
Breast Cancer Research and Treatment|November 20, 2008
Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevanceStella Apostolaki, Maria Perraki, Galatea Kallergi, et al.
Clinical Lung Cancer|May 10, 2011
Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II studyAthanasios G Pallis, Kostas Syrigos, Athanasios Kotsakis, et al.
Plos One|August 21, 2019
An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancerJean-Louis Pujol, Amandine Coffy, Andrea Camerini, et al.
Pageof 13